Statins, fibrates, and venous thromboembolism: a meta-analysis.

@article{Squizzato2010StatinsFA,
  title={Statins, fibrates, and venous thromboembolism: a meta-analysis.},
  author={Alessandro Squizzato and Matteo Galli and Erica Romualdi and Francesco Dentali and Pieter Willem Kamphuisen and Luigina Guasti and Achille Venco and Walter Ageno},
  journal={European heart journal},
  year={2010},
  volume={31 10},
  pages={
          1248-56
        }
}
AIMS The aim is to make a systematic review of the literature to assess the effect of lipid-lowering drugs on venous thromboembolism (VTE) occurrence. METHODS AND RESULTS MEDLINE and EMBASE databases were searched to identify studies that evaluated the effect of lipid-lowering drugs, in particular statins and fibrates, on VTE risk until April 2009. A scoring system was used to divide studies into two quality categories. Odds ratios (ORs) and 95% confidence intervals (CIs) were then calculated… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 34 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 38 REFERENCES

A randomized trial of rosuvastatin in the prevention of venous thromboembolism.

  • The New England journal of medicine
  • 2009
VIEW 13 EXCERPTS
HIGHLY INFLUENTIAL

A new indication for statins to prevent venous thromboembolism? Not yet.

  • Journal of thrombosis and haemostasis : JTH
  • 2009
VIEW 9 EXCERPTS
HIGHLY INFLUENTIAL

Statins and blood coagulation.

  • Arteriosclerosis, thrombosis, and vascular biology
  • 2004
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

HMG-CoA reductase inhibitors are associated with a reduced risk of venous thrombosis

AS Ramcharan, KJ van Stralen, AK Mantel-Teeuwisse, FR Rosendaal, CJM. Doggen
  • J Thromb Haemost 2009;7:514–520
  • 2009
VIEW 5 EXCERPTS
HIGHLY INFLUENTIAL

Statins and the risk of idiopathic venous thromboembolism.

  • British journal of clinical pharmacology
  • 2002
VIEW 3 EXCERPTS
HIGHLY INFLUENTIAL